Drug induced aseptic meningitis: Difference between revisions

No edit summary
Line 6: Line 6:
*Higher predominance in SLE and female gender
*Higher predominance in SLE and female gender


==Causes==
===Causes===
*[[NSAIDs]]
*[[NSAIDs]]
**Most common cause  
**Most common cause  
Line 34: Line 34:
**[[Allopurinol]]
**[[Allopurinol]]


==Clinical presentation==  
==Clinical Freatures==  
*[[Headache]]
*[[Headache]]
*[[Fever]]
*[[Fever]]
Line 43: Line 43:
*Less common symptoms include rash, arthralgia, myalgia, facial edema
*Less common symptoms include rash, arthralgia, myalgia, facial edema


==Diagnosis==
==Differential Diagnosis==
 
 
==Evaluation==
*Drug history with focus on time of ingestion and symptom onset
*Drug history with focus on time of ingestion and symptom onset
*CSF studies
*CSF studies
Line 55: Line 58:
**Due to associated risk, should only be done if suspected drug is irreplaceable
**Due to associated risk, should only be done if suspected drug is irreplaceable


==Treatment==
==Management==
*Discontinuation of offending agent
*Discontinuation of offending agent
==Disposition==
==See Also==


==References==
==References==
Moris, G, Garcia-Monco, JC. The Challenge of Drug-induced Aseptic Meningitis. Arch intern med. 1999 Jun 14; 159 (11): 1185-94
<references/>


Nettis, E, Calogiuri, G, Colanardi, MC, Ferrannini, A, Tursi, A. Drug-induced Aseptic Meningitis. Current Drug Targets - Immune, Endocrine & Metabolic Disorders, 2003, 3, pp. 143-149
[[Category:ID]]
[[Category:Pharmacology]]

Revision as of 05:43, 7 September 2017

Background

  • Abbreviation: DIAM
  • Two proposed mechanisms
    • Direct meningeal irritation by intrathecal drug
    • Hypersensitivity reaction to drug (type III and IV)
  • Higher predominance in SLE and female gender

Causes

Clinical Freatures

Differential Diagnosis

Evaluation

  • Drug history with focus on time of ingestion and symptom onset
  • CSF studies
    • Pleiocytosis (primarily neutrophilic)
    • Elevated protein levels
    • Normal glucose
    • Negative cultures
  • Challenge test with suspected drug
    • Only confirmatory test
    • Requires informed written consent
    • Due to associated risk, should only be done if suspected drug is irreplaceable

Management

  • Discontinuation of offending agent

Disposition

See Also

References